Total Payments
$12,575
2024 Payments
$1,272
Companies
31
Transactions
226
Medicare Patients
6,355
Medicare Billing
$423,297
Payment Breakdown by Category
Food & Beverage$12,522 (99.6%)
Education$52.10 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,522 | 222 | 99.6% |
| Education | $52.10 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,139 | 22 | $0 (2024) |
| PFIZER INC. | $1,075 | 24 | $0 (2024) |
| Journey Medical Corporation | $922.03 | 15 | $0 (2021) |
| Incyte Corporation | $860.40 | 8 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $734.32 | 9 | $0 (2024) |
| GENZYME CORPORATION | $712.95 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $679.12 | 15 | $0 (2023) |
| Amgen Inc. | $609.35 | 15 | $0 (2023) |
| Galderma Laboratories, L.P. | $587.49 | 11 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $565.20 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,272 | 17 | UCB, Inc. ($267.12) |
| 2023 | $1,902 | 33 | Incyte Corporation ($376.58) |
| 2022 | $1,563 | 22 | ABBVIE INC. ($505.82) |
| 2021 | $1,139 | 15 | VYNE Pharmaceuticals Inc. ($341.59) |
| 2020 | $350.41 | 8 | Galderma Laboratories, L.P. ($120.84) |
| 2019 | $2,616 | 51 | Journey Medical Corporation ($624.53) |
| 2018 | $1,672 | 37 | PFIZER INC. ($445.57) |
| 2017 | $2,061 | 43 | Amgen Inc. ($387.70) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $132.14 | General |
| 06/26/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $126.90 | General |
| 06/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $56.97 | General |
| Category: Immunology | ||||||
| 06/02/2023 | Sun Pharmaceutical Industries Inc. | Absorica LD (Drug), Winlevi | Food and Beverage | In-kind items and services | $111.07 | General |
| Category: Dermatology | ||||||
| 05/30/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $116.49 | General |
| Category: Dermatology | ||||||
| 05/30/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.10 | General |
| 05/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $20.45 | General |
| 05/18/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $3.74 | General |
| 05/15/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $11.53 | General |
| Category: Dermatology | ||||||
| 05/08/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: Inflammation | ||||||
| 05/03/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $51.72 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2023 | Galderma Laboratories, L.P. | EPSOLAY (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: ROSACEA | ||||||
| 03/31/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: Dermatology | ||||||
| 03/07/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $112.95 | General |
| Category: Immunology | ||||||
| 03/07/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Inflammation | ||||||
| 02/28/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.09 | General |
| 02/20/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $66.04 | General |
| Category: Dermatology | ||||||
| 02/14/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/09/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $122.71 | General |
| Category: Dermatology | ||||||
| 02/06/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,304 | 4,401 | $302,279 | $154,189 |
| 2022 | 18 | 2,325 | 4,303 | $310,042 | $150,965 |
| 2021 | 12 | 871 | 1,455 | $110,766 | $60,376 |
| 2020 | 12 | 855 | 1,619 | $113,097 | $57,767 |
Total Patients
6,355
Total Services
11,778
Medicare Billing
$423,297
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 579 | 824 | $90,640 | $49,556 | 54.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 353 | 444 | $43,068 | $16,214 | 37.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 189 | 213 | $27,903 | $14,052 | 50.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 273 | 436 | $19,045 | $11,377 | 59.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 69 | 84 | $17,892 | $10,554 | 59.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 279 | 1,783 | $23,179 | $8,711 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $13,390 | $6,789 | 50.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 122 | 137 | $9,864 | $5,528 | 56.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 35 | 41 | $8,446 | $4,617 | 54.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 49 | 52 | $7,800 | $4,287 | 55.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 37 | $4,995 | $3,545 | 71.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 37 | 42 | $6,510 | $3,345 | 51.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 60 | $7,500 | $3,111 | 41.5% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 21 | $3,843 | $2,517 | 65.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $2,940 | $1,779 | 60.5% |
| 11400 | Removal of noncancer skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 16 | 18 | $2,628 | $1,625 | 61.8% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 20 | 26 | $3,250 | $1,441 | 44.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $2,604 | $1,434 | 55.1% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $2,275 | $1,330 | 58.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 13 | $2,275 | $1,097 | 48.2% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 11 | 16 | $1,280 | $752.95 | 58.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 13 | 14 | $952.00 | $527.45 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 610 | 826 | $90,860 | $49,591 | 54.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 372 | 453 | $45,936 | $16,932 | 36.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 198 | 224 | $31,354 | $16,003 | 51.0% |
About Dr. John Morello, M.D
Dr. John Morello, M.D is a Dermatology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720272644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Morello, M.D has received a total of $12,575 in payments from pharmaceutical and medical device companies, with $1,272 received in 2024. These payments were reported across 226 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($12,522).
As a Medicare-enrolled provider, Morello has provided services to 6,355 Medicare beneficiaries, totaling 11,778 services with total Medicare billing of $423,297. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology, Clinical & Laboratory Dermatological Immunology
- Location Jacksonville, FL
- Active Since 09/04/2007
- Last Updated 12/11/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720272644
Products in Payments
- OPZELURA (Drug) $860.40
- EUCRISA (Drug) $854.14
- DUPIXENT (Biological) $673.82
- Exelderm (Drug) $624.53
- EPIDUO FORTE (Drug) $534.04
- COSENTYX (Biological) $507.30
- Enbrel (Biological) $479.09
- SKYRIZI (Biological) $430.65
- RINVOQ (Biological) $413.82
- TREMFYA (Drug) $373.52
- DUOBRII (Drug) $278.71
- Bimzelx (Biological) $267.12
- AMZEEQ (Drug) $246.84
- LIBTAYO (Biological) $238.25
- DORYX (Drug) $232.81
- Trianex (Drug) $231.59
- Tremfya (Drug) $225.00
- Winlevi (Drug) $211.61
- ACZONE (Drug) $202.27
- Impoyz (Drug) $182.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Jacksonville
Dr. Pearl Kwong, Md Phd, MD PHD
Dermatology — Payments: $2.8M
Dermatology $2.8M
Michael Bernhardt, Md, MD
Dermatology — Payments: $702,961
Dermatology $702,961
Kristen Stewart, M.d, M.D
Dermatology — Payments: $107,300
Dermatology $107,300
Jason Sluzevich, Md, MD
Dermatology — Payments: $61,523
Dermatology $61,523
Dr. Douglas Robins, Md, MD
Dermatology — Payments: $24,873
Dermatology $24,873
Jean Mcclintock, Md, MD
Dermatology — Payments: $14,036
Dermatology $14,036